Congenital hypothyroidism
Screen-positive, start early · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Congenital hypothyroidism is the commonest preventable cause of neurodevelopmental impairment, usually detected by newborn bloodspot screening before symptoms appear. Early thyroxine replacement — ideally within the first 1-2 weeks of life — is essential to protect the developing brain.
Red flags
- Markedly elevated screening TSH with very low free T4
- Delay beyond 2 weeks of age in starting treatment
- Features of severe hypothyroidism (prolonged jaundice, poor feeding, constipation, hypotonia, large fontanelle, goitre)
- Suspected central hypothyroidism with other pituitary hormone deficiency
- Non-adherence/absorption failure on follow-up
Assessment
Differential diagnosis
- Primary CH (thyroid dysgenesis or dyshormonogenesis)
- Central/secondary (hypothalamic-pituitary) hypothyroidism
- Transient hypothyroidism (iodine exposure, maternal antithyroid drugs, maternal TSH-receptor-blocking antibodies)
- Preterm/sick euthyroid changes
- Prematurity-related transient hypothyroxinaemia
Investigations
- Newborn bloodspot screening TSH (primary screen) — act urgently on positives
- Confirmatory venous free T4 and TSH
- Thyroid ultrasound and/or radionuclide (Tc/iodine) scan to define aetiology (do not delay treatment for it)
- Maternal thyroid history and TSH-receptor antibody status if relevant
- Thyroglobulin and urinary iodine in selected cases
- Knee X-ray for distal femoral epiphysis (marker of intrauterine hypothyroidism) if indicated
Management
- Treat a screen-positive/confirmed case as urgent — the priority is prompt thyroxine, not complete work-up
- Take confirmatory venous free T4 and TSH, then start treatment without waiting if screening strongly positive
- Start levothyroxine at 10-15 microgram/kg once daily, crushed in a little water/milk, by mouth
- Use the higher end of the range for severe cases (very high TSH, very low T4)
- Recheck free T4 and TSH within 1-2 weeks of starting and after dose changes
- Titrate to normalise free T4 quickly and keep TSH in the target range
- Arrange aetiological imaging (ultrasound/scan) but never delay treatment for it
- Avoid giving thyroxine with soya, iron or calcium feeds/preparations that impair absorption
- Counsel parents on adherence, administration technique and the importance of early treatment
- Arrange paediatric endocrinology follow-up with regular biochemical monitoring and developmental surveillance
Drugs & doses
Levothyroxine 10-15 microgram/kg PO once daily (higher end for severe CH), titrated to free T4/TSH
Administer dissolved in a small volume of water or breast milk; avoid co-administration with soya/iron/calcium
Adjust dose by weight gain and serial thyroid function tests
Disposition
Urgent paediatric endocrinology referral and early treatment; regular biochemical and developmental monitoring through childhood. Re-evaluation of the diagnosis around age 3 if aetiology uncertain.
Complications & pitfalls
- Irreversible intellectual disability if treatment delayed
- Growth impairment
- Overtreatment causing craniosynostosis/temperament effects
- Undertreatment with persistent developmental risk
- Missed associated pituitary deficiencies in central CH
Exam pearls
- Screening detects it before clinical signs — act on positives within days, not weeks
- Outcome is excellent with timely, adequate replacement; delay is the enemy
- The TSH-based newborn screen can miss central hypothyroidism — stay alert to clinical signs
- Soya, iron and calcium reduce levothyroxine absorption — separate their timing
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.